Omega-3 in an IV for newborns with breathing circulation problems
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial tests whether giving an omega-3 fat medicine through an IV (along with standard care) improves breathing and blood-flow problems in newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. It may help reduce strain on the lungs and heart by targeting inflammation and blood-vessel changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is planned to receive TPN (nutrition through a vein) for at least 7 days
- Your baby has been diagnosed with congenital diaphragmatic hernia confirmed by doctors’ tests, including breathing/blood tests and an ultrasound of the heart
- Your baby was born at 34 weeks or later
- Both parents can sign the consent form after the study team explains risks and benefits (with two witnesses)
- Your baby does not have major complex heart problems or certain heart conditions that turn the skin bluish
- Your baby cannot have heavy ongoing bleeding that would prevent safe nutrition through the vein
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
This trial tests whether giving a gas called inhaled nitric oxide helps newborns with a congenital diaphragmatic hernia breathe better and improve lung blood pressure. It's a type of treatment often used to help with lung problems in babies.
This study tests whether breathing in magnesium sulfate and giving sildenafil can improve breathing and lung blood vessel pressure in newborns with persistent pulmonary hypertension. It may help newborns who are having trouble oxygenating despite being on a ventilator.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial tests a portable device that delivers nitric oxide gas to help newborns with severe breathing problems and high blood pressure in the lungs. It aims to see if this treatment improves oxygen levels and supports recovery.
This trial tests whether giving melatonin to full-term newborns with high blood pressure in their lungs (pulmonary hypertension) can help improve their breathing and oxygen levels. It may offer a new treatment option for babies with this condition.
Hear when a new Pulmonary Hypertension of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.